Company cuts losses but increases spend in research and development in face of crisis
Paul Kerr
Northern Ireland pharma research group offering antigens on a commercial basis
Loss narrows as company expands services and introduces new technology
Northern Ireland contract research company says trading in first quarter has been satisfactory
Company will also use funds for existing oncology work and general working capital
Clients of contract research company working on solution to coronavirus outbreak
Commercial roll-out of services in six-month period lifts revenue
Record second half revenues as pharma research group grows US business
Contract research firm says uncertain timing of substantial orders affecting revenues
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times